During the EMT process, TGF-β induces the switch of the FGFR isoform of the epithelial cells, which typically do not bind FGF-2, to a sensitive isoform that binds FGF-2 and promotes cancer progression [11,12]. The gene discussed is FGF2; the disease is cancer.